Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Researchers Awarded Almost £1 Million to Target High Blood Pressure

Published: Tuesday, August 21, 2012
Last Updated: Tuesday, August 21, 2012
Bookmark and Share
Study shows that reduced blood flow to the brain will trigger high blood pressure.

University of Bristol researchers have received funding of almost £1 million from the British Heart Foundation to provide novel therapeutic targets for the treatment of high blood pressure.

Affecting one in three people, the treatment of patients with high blood pressure has important clinical and financial implications for public health.

Although scientists know what factors can trigger high blood pressure many of the mechanisms that regulate the long-term control of blood pressure remain a mystery.

Scientists from the University’s School of Physiology and Pharmacology, who are leading the five-year study, believe that these underlying mechanisms are triggered by poor blood delivery to the brain which responds by pushing blood pressure up causing high blood pressure.

This process re-directs blood into the brain to restore adequate flow. In previous studies, involving patient and an animal model of human hypertension, the blood vessels supplying the brain with blood are narrow and resistant to flow.

They also fail to dilate when brain activity increases, which is a time when more blood flow is needed to deliver oxygen and nutrients. So, there appears a greater susceptibility for stroke in high blood pressure.

The study aims to provide new evidence that shows reduced blood flow to the brain will trigger high blood pressure and provide novel therapeutic targets for the treatment of high blood pressure.

Professor Julian Paton, the study’s lead scientist, said: “You have to consider the brain as the most selfish organ in the body; if it is not satiated with enough blood flow it is the most powerful organ in the body for ramping up the pressure.

“We are absolutely delighted to have been given this award from the British Heart Foundation as it directs much needed attention to the brain and provides the opportunity to come up with new ways to control blood pressure in patients that are devoid of the awful side effects of so many currently prescribed drugs.”

Professor Sergey Kasparov, co-investigator on the study added: “We will attempt to prevent the narrowing of brain arteries in high blood pressure so to improve blood flow, unearth the intra-cranial sensors that detect low brain blood flow that trigger high blood pressure and find out why brain vessels are reluctant to dilate when brain activity increases.”

Dr Hélène Wilson, Research Advisor at the British Heart Foundation (BHF), said: “We’re delighted to award almost £1 million to this Bristol team for their work on understanding the causes of high blood pressure, which can lead to greater risk of having a heart attack or stroke. This latest project is looking at a possible role for the brain in effective blood pressure control, and is part of a wide research programme that we hope will help lead us towards new treatments in the future."

The study, entitled ‘Brainstem hypoperfusion as a causative mechanism for neurogenic hypertension’ led by Professor Julian Paton at the University of Bristol, is funded by a British Heart Foundation grant of £980,415.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
Monday, May 23, 2016
Faster, Cheaper Way to Produce New Antibiotics
A novel way of synthesising a promising new antibiotic has been identified by scientists at the University of Bristol.
Thursday, May 05, 2016
New Findings Could Influence the Development of Therapies to Treat Dengue Disease
New research into the fight against Dengue may influence the development of anti-viral therapies that are effective against all four types of the virus.
Monday, August 05, 2013
Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration
A study to investigate Alzheimer’s disease led by scientists at the University of Bristol has been awarded funding by the Medical Research Council (MRC).
Tuesday, November 06, 2012
Scientific News
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Modified Microalgae Converts Sunlight into Valuable Medicine
A special type of microalgae can soon produce valuable chemicals such as cancer treatment drugs and much more just by harnessing energy from the sun.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
Paper Filter Can Remove Viruses from Water
A new paper filter can purify water from viruses, even the most difficult and contagious.
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
New HIV Vaccine Target Discovered
NIH-Led team have discovered a new vaccine target site on HIV.
Mimicking Evolution to Create Novel Proteins
A study by researchers in the Kuhlman lab offers a new route to design the 'cellular machines' needed to understand and battle diseases.
Antibody Therapy Opens Door to Potential New Treatment for HIV
Researchers at Rockefeller University show how a broadly neutralizing antibody could be used to help fight HIV.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!